Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Late Thursday, New York-based Warburg announced an agreement to buy ECN, run by entrepreneur and chief executive officer ...

Odyssey Math Tuition launches JC 1 H2 Math online tuition elearning course in Singapore, featuring a proprietary MOE-aligned ...